Biotech

All Articles

Turnstone gives up 60%, shocks C-suite to extend cash money

.Turnstone Biologics is actually decreasing its own head count through 60% and also agitating its C-...

Gilead surrenders on $15M MASH bet after weighing preclinical data

.In a year that has observed a permission and also a range of readouts for metabolic dysfunction-ass...

Texas biotech axes cancer cells treaty, pins hopes on obesity

.Alaunos Therapies is actually axing a contract with Precigen, giving up licensing rights to a custo...

Capricor portions a lot more records for DMD treatment after starting BLA

.Capricor Rehabs is taking a victory tour for their phase 2 Duchenne muscular dystrophy (DMD) trial....

FDA spots Kezar lupus trial in grip following 4 patient fatalities

.The FDA has put Kezar Life Sciences' lupus trial on grip after the biotech flagged 4 fatalities dur...

Phase 3 Intellectual Rock trial attacks SMA goal, delivering stockpile 200%

.A period 3 test of Scholar Stone's back muscle atrophy (SMA) candidate has hit its primary endpoint...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream point out $182M plan

.RNA biotech CAMP4 Therapeutics has defined plans for a $67 million IPO, with inflammation-focused U...

Galecto purchases leukemia medication, loses bone cancer asset in pivot

.A year after the breakdown of an idiopathic lung fibrosis prospect delivered Galecto on a search fo...

Judo throws down $100M to knock out kidney health condition

.Taking the mat is actually Judo Biography, a promising biotech equipped with $one hundred thousand ...

AstraZeneca pays CSPC $100M for preclinical heart problem drug

.AstraZeneca has settled CSPC Pharmaceutical Group $100 million for a preclinical heart attack medic...